PT-2026-50822 · Apollo Pharmacy · Blood Glucose Monitoring System

Publicado 2026-06-18 · Atualizado 2026-06-19 · CVE-2026-52866

NVD

CVSS v3.1

6.5

Média

Vetor base

AV:A/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.

Correção

Missing Authorization

Enumeração de Fraquezas

CWE-862

Identificadores relacionados

CVE-2026-52866

Produtos afetados

Blood Glucose Monitoring System

Referências · 5

• https://cisa.gov/news-events/news/understanding-bluetooth-technology · Nota
• https://nvd.nist.gov/vuln/detail/CVE-2026-52866 · Nota de Segurança
• https://apollopharmacy.in/contact-us · Nota
• https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2026/icsma-26-169-01.json · Nota
• https://cisa.gov/news-events/ics-medical-advisories/icsma-26-169-01 · Nota